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Abstract
Background: Recent telehealth studies have demonstrated minor impact on patients affected by long-term
conditions. The use of technology does not guarantee the compliance required for sustained collection of
high-quality symptom and physiological data. Remote monitoring alone is not sufficient for successful disease
management. A patient-centred design approach is needed in order to allow the personalisation of interventions
and encourage the completion of daily self-management tasks.
Methods: A digital health system was designed to support patients suffering from chronic obstructive pulmonary
disease in self-managing their condition. The system includes a mobile application running on a consumer tablet
personal computer and a secure backend server accessible to the health professionals in charge of patient
management. The patient daily routine included the completion of an adaptive, electronic symptom diary on
the tablet, and the measurement of oxygen saturation via a wireless pulse oximeter.
Results: The design of the system was based on a patient-centred design approach, informed by patient
workshops. One hundred and ten patients in the intervention arm of a randomised controlled trial were
subsequently given the tablet computer and pulse oximeter for a 12-month period. Patients were encouraged,
but not mandated, to use the digital health system daily. The average used was 6.0 times a week by all those
who participated in the full trial. Three months after enrolment, patients were able to complete their symptom
diary and oxygen saturation measurement in less than 1 m 40s (96% of symptom diaries). Custom algorithms,
based on the self-monitoring data collected during the first 50 days of use, were developed to personalise
alert thresholds.
Conclusions: Strategies and tools aimed at refining a digital health intervention require iterative use to enable
convergence on an optimal, usable design. ‘Continuous improvement’ allowed feedback from users to have an
immediate impact on the design of the system (e.g., collection of quality data), resulting in high compliance
with self-monitoring over a prolonged period of time (12-month). Health professionals were prompted by
prioritisation algorithms to review patient data, which led to their regular use of the remote monitoring website
throughout the trial.
Trial registration: Trial registration: ISRCTN40367841. Registered 17/10/2012.
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Background
The term ‘digital health’ is used to encompass a wide range
of technologies that include mHealth, telehealth, and con-
nected health [1, 2]. In this paper, we specifically refer to
the use of complex mobile health solutions for the remote
monitoring and management of patients. In these scenarios,
patients typically transmit their vital-sign data to healthcare
professionals (HCP) in real-time. In most cases, the aim of
the digital health system is to monitor the patient’s well-
being remotely between visits to their clinician [3].
In recent years, many research groups have tried to
design or adapt technical solutions for patients with
chronic conditions [4–8], however, problems encoun-
tered include difficulties experienced by patients when
using the technical solution, low compliance rates, and
lack of personalisation (for example, restricting the use
to specific times during the day) [9].
Similar observations have been reported in recent sys-
tematic reviews [4, 10, 11]. For example, O’Connor et al.
[10] reviewed how patients and the public engage with
and enrol in a broad range of digital health interventions.
They recommended that digital health products and ser-
vices should be tailored to lessen rather than increase the
self-care burden of treatment. The aim should be to inte-
grate digital health with patients’ current lifestyle, as a
one-size fits all approach is unlikely to be effective.
Despite such limitations that may impact on usability,
there have been a number of recent randomised con-
trolled trials (RCTs) of telehealth interventions for the
management of chronic conditions such as chronic ob-
structive pulmonary disease (COPD) [4–8, 12–15]. The
three large-scale RCTs of long-term monitoring including
people with COPD have found little or no substantial
benefit for the participants [5–8], and have called for add-
itional, better targeted RCTs [4]. Some smaller-scale trials
have reported positive outcomes in terms of quality of life
(QoL) improvement [14, 15], reduced risk of emergency
department attendance and hospitalisation [13]. The
Whole-System Demonstrator trial in the UK found little
effect on the risk of death [5]. However, an evidence syn-
thesis [16] suggested that there was an absence of high-
quality evidence for management of COPD compared to
other chronic conditions (e.g., heart failure, diabetes).
One of the main challenges to effective implementation
of digital health systems is a lack of compliance with the
use of technology. An extensive mixed-methods study
[17], identified engagement from both patients and profes-
sionals as being key to the success of a telehealth interven-
tion and noted the challenges faced by studies that had
struggled to engage participants and clinicians.
In general, previous studies have shown that partici-
pants are receptive to the use of telemonitoring as a self-
management approach. Generic telehealth literature re-
views [11, 18] show an initial high level of acceptance
and satisfaction with the telehealth systems employed in
the studies considered, and, in several cases, there was a
high level of compliance with self-monitoring.
However, even amongst well-designed studies, [11, 18]
compliance tends to decrease over time, most rapidly in the
period immediately after the beginning of the studies. Com-
pliance beyond the initial period depended on the interven-
tion type, on the condition treated, and on the characteristics
of the patient population involved. Higher levels of compli-
ance throughout the studies were associated with the follow-
ing characteristics: low-burden and short interventions, type
of chronic condition (for example, higher compliance with
heart failure patients) and the age of the patients. The
authors of both reviews identify this decrease in adherence
over time as a critical issue to be addressed and further in-
vestigated, as chronic illnesses require long-term monitoring.
The literature on compliance with telehealth interventions
points to the importance of integrating components into the
intervention that promote both adoption and retention.
Solutions proposed in the literature include: conveying in-
formation correctly and appropriately, lowering the entry
barrier by softening the perception that some patients have
of telehealth systems as being too ‘difficult’ to use, and en-
hancing the sensation of empowerment that patients feel
when using effective telehealth solutions [11, 18–20]. If
those conditions are met, the patients are more likely to en-
gage and maintain long term compliance with the system.
Considerations of compliance led us to three observa-
tions that underpin the design of our digital health system
and its subsequent use in clinical studies with COPD pa-
tients [21]: (i) the use of remote monitoring on its own
may not be sufficient to guarantee the success of a tele-
health/digital health intervention. An effective digital
health strategy must also include a self-management com-
ponent; (ii) one-size-fits-all approaches to both the design
of the mobile applications and the alerting algorithms are
prone to failure since they do not take into account nat-
ural variations in patient physiology or behaviour and (iii)
state-of-the-art technology (based on the convergence of
communications and computing) should be the basis for
modern, scalable digital health platforms. These observa-
tions are aligned with the conclusions of several papers
and systematic reviews on the topic of telehealth applied
to the management of chronic conditions [4, 10–12, 17,
19, 20, 22]. Based on these observations, the digital health
system that we designed includes a self-management com-
ponent as well as self-monitoring, and was personalised as
much as possible to the patient’s needs.
Gregersen et al. [4] call for more research on the
evaluation of digital health systems through large-scale
controlled trials. It was therefore our intention to
evaluate our novel digital health solution at scale in the
context of a randomised controlled trial, provided that
preliminary testing with patients was successful.
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The system was initially tested in a pilot study with 23
COPD patients [23]. The results of this pilot study were
sufficiently positive to justify the design and implementa-
tion of an RCT using 2:1 allocation to examine experience
with the intervention in detail. Both the pilot study and the
RCT were part of the sElf-management anD support
proGrammE (EDGE) project [21].
In this paper, we discuss the potential for patient-
centred design to achieve highly usable and effective
digital health applications for self-monitoring and self-
management; we describe the strategies which we devel-
oped during the pilot study to achieve high-quality vital-
sign recording in a home setting; and we present the re-
sults on usage of the system by patients in the RCT, ana-
lysing in detail the data recorded by the 110 patients
who used the EDGE system for the 12 months of the
trial. The analysis of the primary and secondary out-
comes of the RCT is presented in a parallel clinical
paper (Farmer AJ, Williams V, Velardo C, Shah SA, Yu
L-M, Rutter H, et al.: Self-management support using an
Internet-linked tablet computer compared with usual
care for chronic obstructive pulmonary disease: results
of a randomised controlled trial, submitted).
Methods
This section describes the following: (a) the EDGE digital
health system; (b) the methodology employed during its
design; (c) the RCT in which the system was deployed;
and (d) the data analysis phase.
System architecture
The system architecture for the EDGE digital health sys-
tem (Fig. 1) comprises a general-purpose tablet com-
puter running on the Android operating system, a
backend server within the local National Health Service
(NHS) network, and a third-party server (Amazon S3).
A mobile application (“the application”) was developed
to run on the tablet computer: it collected self-reported
questionnaire and pulse oximeter data from the patient,
and synchronised them stripped of personal identifiers
automatically with the NHS server (backend system), for
security reasons the tablet did not contain any personal
information (e.g., name or date of birth). Each informa-
tion exchange was based on pseudonymised data trans-
mitted over a secure link, a tablet would be identified by
an identifier generated on the server at the moment of
the configuration. Data were stored in the backend ser-
ver hosted within the local NHS network, behind its fire-
wall. Here data storage and data analysis tasks ran in
parallel to summarise and report the status of each pa-
tient to the healthcare professionals. The clinical and
technical teams could interact with the system to con-
figure new kits, monitor data from a web application
customised for the task, and effectively communicate
with the patient through text messages. Access was
granted only to the clinical team that participated to the
study and to researchers covered by NHS Research Pass-
port.1 Finally, a high-speed download link was provided
by a third-party server (Amazon S3) in order to distribute
videos and documents to be downloaded by the Android
Fig. 1 System overview: the Android mobile application sends data to a secure web server within the NHS network where data are stored. The
data can be screened by the clinical team through a web application
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application so as to provide self-management information,
personalised to each patient’s needs. The third-party ser-
vice was chosen because it provided us with larger band-
width than the NHS link, but no patient data were ever
stored on the third-party server.
We decided to use a backend server inside the local
NHS network protected by its tightly-controlled security
firewall to ensure a high level of data security. At the
same time, the mobile application did not contain nor
transferred any personal information which could iden-
tify the patient to the server. All communications used a
Transport Layer Security certificate signed from certifi-
cation authority (DigiCert Inc.), and an electronic sig-
nature validated each connection before data were
accepted and stored in the backend server. The server
was equipped with technologies (e.g., Matlab and Py-
thon) to enable the design of algorithms for automatic
data quality control, signal analysis, and data reporting.
The patients’ use of the application (buttons clicked,
sections visited, time of use) was monitored in the back-
ground via an internal logger and usage data, in addition
to the vital sign values and answers to the patient diary
questions, were uploaded to the backend server. A simi-
lar log system was employed on the backend server to
monitor nurse access to the web portal.
Co-design of the EDGE digital health system
A usability assessment, talk-aloud session was conducted
with a group of 10 patients to test a prototype version of
the patient application on both a 7” and on a 10.1” com-
puter tablets. The bigger tablet PC was preferred by pa-
tients to the smaller version because it provided a much
larger display, with the possibility of displaying text with lar-
ger fonts, and because it gave a better handheld experience.
To enhance usability we included the following: a sim-
ple interface (no keyboard); videos and other multimedia
content to facilitate conveying information correctly and
appropriately; and user-friendly procedures (supported
by signal-quality algorithms) to ensure the collection of
high-quality data, thus lowering the technical barriers
for the competent use of the system. Instead of a be-
spoke tele-health box, we employed an Android tablet
with Bluetooth communication to an external oximeter.
For the pilot phase, each kit was therefore composed
of an Android tablet PC (Samsung Galaxy Tab 2) and
a finger pulse oximeter (Nonin 9560 Onyx). The equip-
ment was handed out by a research nurse, together with
a leaflet that explained the basic maintenance of the
tablet PC (turning on/off and recharge) and of the
pulse oximeter (changing batteries).
The application design, especially the self-management
module, required a careful analysis of patients’ needs.
Consequently, feedback from the clinical collaborators
and the patients was crucial in the design of the applica-
tion. Our design process, analogous to our previous work
[24], made sure that the patients’ feedback was collected
during two co-design workshops (attended by focus groups
of COPD patients), and during several home visits (when
research engineers and/or research nurses met patients for
prototype evaluation). Patients’ feedback was then discussed
during weekly or monthly meetings between the healthcare
professionals and the technical team, so that appropriate
changes to the digital health system were implemented
and tested as soon as possible. The result of these it-
erations (Appendix Figure 7) led to an easy-to-use
and intuitive interface for the application that needed
no additional information (e.g., operation manual) to
explain how to use its functionalities.
Twenty-three patients with different COPD severity
levels were recruited to help in the design of the pilot
study, during which multiple features were designed and
tested before finalising the version of the application for
the randomised controlled trial phase. The research
team agreed through consensus and guidance by clinical
experts which features to incorporate in the EDGE sys-
tem, following a ‘continuous improvement’ approach.
Use of EDGE digital health solution in RCT
The randomised controlled trial involved 166 COPD
patients (56 in the usual care group, 110 in the digital
health intervention group, Appendix Table 1). The pro-
gress of the trial was reviewed by the research team in
monthly meetings where feedback from patients, carers,
and the research nurses was discussed.
Data collection and data quality
One of the main advantages of digital health, compared to
conventional care, is the possibility of administering ques-
tionnaires systematically, and collecting health-related
data remotely and directly from the patient while they are
in their home environment. Therefore, one of the main
non-functional requirements of such solutions should be
the reliability of the data collected [25]. Especially when
designing self-management modules, digital health system
designers have to ensure that all measures have been
employed to guarantee reliable data collection.
With the EDGE system, participants were asked to record
on the computer tablet their answers to the symptom ques-
tions daily, and their answers to the anxiety and depression
questions monthly. The application did not mandate pa-
tients to complete their diary at a specific time of the day,
in order to allow for greater flexibility and the freedom to
choose a time that suited their daily routine (Fig. 2). To
allow the clinical team to track participants ‘emotional
well-being’, anxiety and depression questionnaires, based on
a combination of PHQ-2, GAD-2, PHQ-8, and GAD-7
questionnaires [26, 27], each had to be answered monthly.
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The score computed from each questionnaire was used to
select a set of videos to be proposed to the patient at the end
of the data-entry session. The number of questions asked
was adjusted according to pre-defined flow diagrams and the
answers given to the questions by the patient. If the answers
indicated a major increase in anxiety and depression, then
that patient was flagged to his or her General Practitioner.
As part of the daily routine, each patient also had to
record pulse oximetry data for 30 s (generating pulse
rate and oxygen saturation data at a rate of 3Hz). There
is recent evidence that oxygen saturation readings from
a pulse oximeter heighten patients’ awareness of their
condition and gives them confidence to make improved
self-management decisions [28]. The pulse rate and oxy-
gen saturation measurements were transferred automat-
ically via Bluetooth by the pulse oximeter to the tablet,
together with the entire photoplethysmographic signal
(the cardiac-synchronous waveform recorded by the
pulse oximeter, here at a rate of 75 Hz).
Patients were introduced to the use of their kit by a
community respiratory nurse at the first visit to their
home after being allocated to the intervention group in
the RCT and were asked to use their tablet computer on
a daily basis at a time that would suit their daily routine.
The application design was divided into three modules.
The data collection module allowed the patient to record
their answers to simple questions in the patient diary
and also their pulse oximetry data (pulse rate and oxy-
gen saturation values) simply by placing their finger in
the pulse oximeter probe. The communication module
ensured that the clinical team could send messages to
the patient (e.g., a message from the nurse to help set up
a home visit, or a message advising a visit to the general
practitioner (GP)). Lastly, the self-management module
offered patients feedback about their physical well-being
(through the use of graphs of their vital sign values and
of their answers to the symptom diary questions), motiv-
ational and psychological support (e.g., through the use
of videos demonstrating respiration techniques, or help-
ing to manage anxiety and mood related issues).
The content of the self-management section was re-
motely configured for each patient by the clinical team and
the content could be personalised to match the current
profile of the patient (e.g., back-up medication information,
oxygen use, and smoking cessation information).
Although the positive aspects of digital health such as the
possibility of daily monitoring, personalised care delivery,
and reduction of unwanted biasing effects (e.g., the “white
coat effect” in the case of blood pressure measurements),
home monitoring systems require patients to report their
symptoms and record their vital signs with no help. The
lack of specialised support might increase the chances of
human error in recording the answers to the symptom
diary questions and using the medical equipment (here the
pulse oximeter). Therefore, appropriate techniques for data
quality check were considered during the design of the
EDGE digital health intervention. Several solutions for both
symptom reporting and vital sign recording were employed
to improve the reliability of data collection.
For symptom self-reporting we employed a ‘select and
continue’ approach that allowed patients to ‘select’ their
answer and then ‘continue’ with the next question/symp-
tom, thus allowing them the time to change their mind as
many times as they deemed necessary before continuing.
To ensure that the Bluetooth-enabled pulse oximeter
was used effectively and generated high-quality data, ex-
planatory text, images, and videos were assembled to show
how to take a reading. Moreover, a feedback mechanism
alerted the patient when data of poor quality were being
recorded. For example, a message prompted patients to sit
with their hand still, their wrist flat on a surface, and with
their finger in the pulse oximeter for the whole duration
of the oxygen saturation recording (30 s).
The signal quality index provided by the manufacturer
(Nonin Inc.) was put to good effect. If poor signal qual-
ity was detected, the EDGE application would extend
the recording time for a further10 s. If this failed to pro-
vide sufficiently high quality data (a continuous record-
ing with no artefact for 30 s), patients would be
presented with the option to attempt recording a second
time. Recording would not be attempted a third time;
the data would be accepted as ‘best effort’, not displayed
to the patient, but still transmitted to the server for re-
search purposes alongside the signal quality information.
Self-management and exacerbation management
Previous versions of digital health systems have followed a
paradigm of regular clinical review of all patient data to
Fig. 2 Time of use of the EDGE application by the intervention group
participants during the RCT. The majority of patient diary sessions took
place in the morning or afternoon, but a non-negligible number of
diaries were completed at night
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allow clinicians to exercise clinical judgment about the
need for clinical intervention. The approach we undertook
in the EDGE project was to recognise that patients are not
in need of attention when they are well. We hypothesised
that data could be obtained during the study to help de-
fine patients as either requiring, or not requiring, nurse
review. Patients recognised as requiring the immediate at-
tention of the respiratory nurse were prioritised for urgent
follow-up, and their profile reviewed, Priority was assigned
according to the number of ‘alerts’ in the most recent two
weeks since the last review. In this context alerts were
generated when the vital sign value (pulse rate or oxygen
saturation) went above (or below) a certain threshold or
the overall symptom score (computed out of nine ques-
tions [23]) went above a certain threshold.
Since the physiology of each patient is different, a robust
alerting mechanism needs to take into account intra- and
inter-person variability. Telehealth systems have tended to
rely on fixed thresholds, or values manually tuned by
health care professionals [5–8]. We relied instead on sig-
nal processing to provide automated, data-driven, perso-
nalised alert thresholds. A training period of 40 data
points (corresponding approximately to the first six weeks
of system usage) was adopted. The training period was
chosen in collaboration with a panel of experts and se-
lected in order to allow time for the patient to become fa-
miliar with the system, and for sufficient symptom and
vital sign data to be collected to characterise that patient.
A univariate approach was chosen at this stage to ana-
lyse the vital sign and symptom score values separately.
From the data acquired during the training period, we
computed the alerting threshold as the value corre-
sponding to the 95th percentile for that parameter (see
Fig. 3). By using this approach for oxygen saturation,
pulse rate, and overall symptom score, we were able to
compute personalised alert thresholds for each patient.
We implemented this approach during the pilot study
to test its viability with the healthcare professionals re-
sponsible for managing the patients and we then used it
during the randomised controlled trial to enable alerting
thresholds to be configured automatically for each patient.
Treating each parameter separately makes the alerting
system easy to understand for the respiratory nurses
reviewing the patient data and straightforward to imple-
ment whilst allowing personalisation to the patient’s data.
Results
In a parallel clinical paper, we present an analysis of the pri-
mary and secondary outcomes of the RCT (Farmer AJ,
Williams V, Velardo C, Shah SA, Yu L-M, Rutter H, et al.:
Self-management support using an Internet-linked tablet
computer compared with usual care for chronic obstructive
pulmonary disease: results of a randomised controlled trial,
submitted). Here we focus on the technical aspects of the
use of our system during the RCT: system usage for the
intervention arm of the RCT (tablet computer usage for self-
monitoring and self-management by patients, and study
website usage for remote patient management by respiratory
nurses), and vital-sign data analysis for personalised alerting.
We report on the data collected by the system, and review
the performance of the algorithms applied to the patient data
collected by the intervention group during the RCT.
Analysis of system usage in the RCT
One hundred and ten participants were involved for a
12-month period: data were included from all partici-
pants allocated to the intervention arm regardless of the
extent to which they used the system.
The time of day chosen to use the application varied
substantially across all patients, with a majority prefer-
ring the morning, while some preferred the evening or
Fig. 3 An illustration of how the alerting thresholds were computed for the symptom diary score (a) and SpO2 data (b) from one patient. From the
top anti-clockwise: (1) raw data points, (2) distribution of the data points, (3) probability density function (PDF), (4) cumulative density function (CDF).
The threshold value is indicated by the small square in the last plot and it is equal to the value corresponding to the 95th percentile (5th in the case of
SpO2). Gaussian kernels were used instead of rectangular ones in order to achieve a smooth PDF and CDF
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late evening to record their symptoms and check the
value of their oxygen saturation.
Most patients completed their diaries within 2 h of
their chosen time (Appendix Figure 10). This confirmed
our assumption that, given enough flexibility, patients
will develop a habit of use, thus increasing compliance.
Patient compliance was defined as the number of days
a week that a patient used the system (so maximum
compliance could only be as high as 7). Overall compli-
ance was then defined as the compliance averaged across
all patients. In Fig. 4 we show the trend of system com-
pliance for all intervention group patients. The value is
stable throughout the RCT, with an average (sd) of 6.0
(0.2) days a week for months 6 to 13 and an average (sd)
of 5.7 (0.2) days a week for months 13 to 20.
The learning curve associated with the use of a new
digital health system also influences the user experience.
We have used the time needed to complete the symp-
tom diary as a proxy to measure the progress of patients.
The data from the interaction log were analysed and the
completion time for each symptom diary was computed.
We grouped the data according to the time since the be-
ginning of the study, and computed twelve cumulative
distribution functions (CDF), one for each month spent
in the study, as shown in Fig. 5. The closer a CDF gets
to the y-axis, the shorter the completion time. The plot
shows that patients become quicker at using the system
during the first three months of use. The majority of
symptom questionnaires (96%) were completed in less
than 1m40s after the third month of use.
The web portal (Appendix Figures 8 and 9) also moni-
tored how the nurse used the system. Over the course of
the trial the nurse accessed the web interface, on average,
33 times ± 15 (range: 11–79) per patient, used the system
to track notes about patients on average 32 times ± 16
(range: 3–79), and changed the medication plan 8 times ± 4
(range: 2–20) per patient. Since each participant was in the
trial for 12 months, the equivalent figures are 2.75, 2.67 and
0.67 times per month. The two research nurses found this
workload to be less than that associated with conventional
care. The system gave the possibility to the research nurse
reviewing the patients’ data during the RCT to dismiss alerts
by accomplishing one of a set of predefined actions on the
patient’s profile. The actions were designed to map the work-
flow of the community nurse team: a) Symptom diary
reviewed - no action required, b) GP/Practice nurse con-
tacted and advised to contact patient, c) Respiratory nurse
contacted and advised to contact patient, d) Community re-
spiratory nurse contacted and symptom diary details handed
over, e) Patient contacted by the research nurse (with details
about the reason), f) Letter sent to GP after GAD/PHQ diary
alert, g) Sign-off (Addition of a visible tick mark on the pa-
tient’s profile, which remained for the next three days).
In case of action (e) and (g) the alerts were then dis-
abled for three consecutive days.
Of all actions, the first one (a) was initiated by the nurse a
total of 5,348 times (48 times per participant, i.e., four times
per month, or once a week), usually in combination with
action (g), which temporarily disabled alerts (3,458 times,
31 times per participant). Other actions were undertaken
far more rarely: (f) 36 times, (e) 35 times, (b) 7 times, (c) 4
times, and (d) 1 time. These data provide clues as to which
actions could be grouped together in the next version of
the digital health system, and which ones to remove.
The health care professionals using the system dis-
abled an average (sd) of 42 (35) alerts per patient. When
Fig. 4 The plot shows the patient compliance with the mobile
application across the study. Compliance (measured as number of
days of usage per week) remained stable throughout the study.
The first 5 and last 4 months of the RCT were not included in the
calculation as they included too few participants to compute
meaningful values
Fig. 5 Learning curve for use of the digital health application: each
line represents the cumulative distribution function (CDF) for the
time needed by each patient to complete the symptom diary, for
the ith - month. Over time, patients become quicker at completing
their symptom diary
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clustering alerts which occurred within a 7-day window,
the number of disabled alerts decreases to an average
(sd) of 20 (11) weeks per patient.
Data quality
Both algorithmic and design features enabled the system
to collect and retain good quality data despite the un-
constrained, home-based use case. As a result, we col-
lected 28,184 data sessions containing both symptom
diary and oximetry data, plus an extra 3508 sessions
with symptom diary only.2 Out of the 28,184 sessions,
26,293 (93.3%) were of high quality and only 1,891 ses-
sions (6.7%) were deemed to be of low quality (due to
motion artefacts).3 As patients recorded their vital signs
after very little training, these results are very promising
and indicate that high-quality data collection should be
possible in large-scale digital health systems.
Vital-sign data analysis
Using the personalised univariate approach developed
during the pilot study allowed us to handle intra-patient
changes automatically. By selecting the threshold based
on the 95th percentile of the data distribution during the
run-in period, we were able to obtain a similar alert rate
(5%) for most patients (those whose physiology did not
change after the run-in period). To demonstrate the
large variability in patient physiology, Fig. 6 shows the
histograms of the threshold values computed by our sys-
tem for the 110 intervention-group patients in the RCT.
The figure indicates that using a single value for the alert
threshold for all patients is sub-optimal; for some pa-
tients, the real alerts would be missed in the midst of a
plethora of false alerts, while for others the same fixed
threshold would lead to alerts being missed.
In order to cope with intra-patient variability over time,
the EDGE digital health system could make the system re-
compute automatically a patient’s alert threshold for a
patient whenever the baseline values for that parameter
changed significantly. This functionality was used for each
patient an average of 4.1 times (±1.3) during the study,
taking into account the fact that there are three threshold
values: one for oxygen saturation, one for heart rate and
once for the overall symptom score.
Discussion
Previous trials have tended to explore the use of telehealth
for long-term self-monitoring using static bespoke equip-
ment, limited patient engagement strategies, and without
offering personalisation of either data collection or feed-
back of data [5–8, 10]. The shortcomings of these systems
have been well rehearsed (for example, see the paper on
the TELESCOT trial reviewed in the Background section
at the start of this paper). It is difficult for us to compare
our system with previous telehealth systems which have
mostly used dedicated hardware systems. The novelty of
our approach lies in the combination of an easy-to-use ap-
plication on a standard computer tablet (Samsung Galaxy
Tab 2), promotion of self-management using videos,
patient-centred design, and personalised alerting. We have
shown that this approach led to very high compliance
figures, sustained throughout a 12-month period, Most
telehealth studies do not report compliance rates for the
intervention group patients (except for self-monitoring of
blood glucose in diabetes) but a recent systematic review
of home telemonitoring in COPD [9] reported difficulties
with use of technology, which in a number of studies led
to low compliance rates.
We have presented the design and development of the
EDGE COPD system and the results of the evaluation of
its use both by patients in the intervention group and
for remote management by respiratory nurses during
a 12-month RCT. Patients were provided with a per-
sonalised application running on an Internet-enabled
computer tablet, providing mobility to those who
wanted to carry on their monitoring while away from
Fig. 6 Distributions of alert thresholds calculated after run-in period for each of the 110 intervention-group patients, for the different data col-
lected: symptom diary score (left histogram), oxygen saturation (center histogram), and heart rate (right histogram)
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home (e.g., when at the hospital or in a different house).
Additionally, the system allowed the recording of self-
monitoring data at any time, thus encouraging the pa-
tient to find the appropriate time that fitted their daily
routine. The data collection process allowed patients to
record high-quality physiological data, with only 6% of
the photoplethysmographic (pulse oximeter) waveforms
affected by motion artefacts.
The work presented here shows the benefits of our
patient-centred approach:
1) enhanced patient compliance, as demonstrated in the
“Analysis of system usage in the RCT” section;
2) improved ease of use and collection of high-quality data
(see the “Data collection and data quality” section);
3) value of adaptive algorithms based on individual
patient physiology, as discussed in the “Self-
management and exacerbation management”
and “Vital-sign data analysis” sections.
Compliance rate and usage-time demonstrate that the
mobile application is easy to use and show that patients
become proficient in completing the symptom diary
within three months.
The compliance measure remained stable throughout
the study, reaching an average of 6.0 times per week per
patient. Usage of the system was consistently high
throughout the duration of the study regardless of age or
gender. With only 110 participants in the intervention
group, it is not possible to carry out a quantitative analysis
of the usage data according to gender, age, COPD severity
or previous computer usage. We have qualitative evidence
[29] however that the system was useful and acceptable
for all the types of patients in our study, regardless of their
level of familiarity with computers.
The data collected demonstrate how the clinical team
engaged with the management website and with the pa-
tient through the functionalities provided by the EDGE
back-end system.
We developed a univariate statistical approach to alert
personalisation which was used to provide immediate feed-
back to the clinical team, and could also provide a baseline
for future attempts at improved algorithms for the detection
of exacerbations [30, 31]. Results from the qualitative study
[29] and from the analysis of the RCT results (Farmer AJ,
Williams V, Velardo C, Shah SA, Yu L-M, Rutter H, et al.:
Self-management support using an Internet-linked tablet
computer compared with usual care for chronic obstructive
pulmonary disease: results of a randomised controlled trial,
submitted) suggest that patients are comfortable with using
the digital health intervention to self-manage their condi-
tion, and that the use of the system may help in reducing
the usage of healthcare resources (practice nurse and GP
visits). Initial results from usability assessment of the website
also confirm high levels of system usability and technology
acceptance from a wide range of professions from the com-
munity respiratory nurses and physiotherapists who interact
with COPD patients on a regular basis.
A limitation of this paper is that we are not reporting
the impact of our digital health system on outcomes (for
example, the frequency of use of primary care) as these re-
sults are presented in a parallel clinical paper. A further
limitation is the fact that our sample size did not allow us
to explore the effect of gender, age, COPD severity or fa-
miliarity with computer technology on the acceptability
and the usage of the system; however, the qualitative study
reported in [29] indicated a positive attitude towards the
usability of the EDGE system. Finally, we were not able to
carry out an investigation of the cost-effectiveness of our
system. The use of computer tablets as devices to access
the internet continues to increase [32]. Future studies will
be able to benefit from using the devices owned by partici-
pants, with sample sizes such as to make the reliable as-
sessment of cost effectiveness feasible.
Conclusion
Usage data for the trial confirm that patient-centred
design and iterative strategies aimed at refining digital
health platforms (e.g., continuous integration) enable
the development of an easy-to-use interface, which
promotes compliance in COPD patients. Long-term,
sustained use of the digital health platform was shown
to be feasible and acceptable to participants. Patients
reported their daily symptoms, medication use, and
were able to measured physiological variables, generat-
ing a large dataset of high-quality data. The healthcare
professionals engaged closely with the system as dem-
onstrated by their regular use of the website for remote
monitoring of patients throughout the trial. We also
demonstrated an effective way of integrating tools for
the generation of personalised alert thresholds in a
large population of individuals. The high levels of
usability and compliance suggest that the platform is
ready for translation into standard care. Following the
end of the RCT, the EDGE-COPD system has been
adopted by a number of respiratory nurses in Oxfordshire
to manage patients remotely.
Endnotes
1http://www.nihr.ac.uk/about-us/CCF/policy-and-standards/
research-passports.htm - last accessed: 13 February 2017
2The section of the app will record a symptom diary but
not an oxygen saturation session in case of problems with
the oximeter (low battery, problems with Bluetooth con-
nection, participants deliberately removing their finger).
3Low-quality data were not displayed on the website.
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Appendix
Table 1 Patient characteristics for the cohort of 110 patients in the intervention group that completed the 12-month randomised
controlled trial
Percentage




>80 year : 9.1%
Gender Male 62% (68)
Female 38% (42)








Fig. 7 Samples of the user interface of the Android mobile application: a main menu, b symptom questionnaire selection, c questionnaire data
entry, d oxygen saturation measurement session summary
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Fig. 8 Main page on the back-end server with the patient list, the number of days since the last measurements or symptom diary session, and
any alerts generated by the data collected through the Android mobile application
Fig. 9 Individual patient page from back-end server, with details of the last 2-week period. In this case the overall symptom score was over the
alerting threshold. The patient responded with a dose of steroids for two days (7–8 June)
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